Validity of mouse mammary tumour models for human breast cancer: Comparative pathology

Research output: Contribution to journalReview article

61 Citations (Scopus)

Abstract

In March 1999, a panel of distinguished pathologists was convened by the U.S. National Institutes of Health Breast Cancer Think Tank to develop a classification of breast lesions based on their examination of 39 models of Genetically Engineered Mice (GEM) associated mouse mammary cancer (Cardiff et al., 2000). The meeting, in Annapolis, Maryland, resulted in a published summary report from the Pathology Panel (Cardiff et al., 2000). The Annapolis consensus report, developed from the Panel's deliberations, pointed out that the mammary lesions of GEM were different from most (spontaneous) mouse mammary tumors and could be divided into three distinct categories: (1) lesions that resemble those found in spontaneous mouse mammary tumorigenesis, (2) lesions that have a unique "signature" tumor phenotype that was specific for the transgene, and (3) lesions that resemble those found in human breast diseases (Cardiff et al., 2000). This review emphasizes the proposed nomenclature and the differences between the models and human breast cancer with the intention of stimulating discussion and the development of new models.

Original languageEnglish (US)
Pages (from-to)224-230
Number of pages7
JournalMicroscopy Research and Technique
Volume52
Issue number2
DOIs
StatePublished - Jan 15 2001

Fingerprint

mammary neoplasms (animal)
pathology
Pathology
lesions (animal)
breast
breast neoplasms
lesions
breasts
mice
Tumors
tumors
cancer
Breast Neoplasms
Breast
Terminology
National Institutes of Health
Breast Diseases
phenotype
Health
neoplasms

Keywords

  • Genetically engineered mice
  • Nomenclature
  • Transplantation
  • Validation

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Anatomy
  • Instrumentation

Cite this

Validity of mouse mammary tumour models for human breast cancer : Comparative pathology. / Cardiff, Robert.

In: Microscopy Research and Technique, Vol. 52, No. 2, 15.01.2001, p. 224-230.

Research output: Contribution to journalReview article

@article{1d5b0b94f804488ca401aacb6f7b0cff,
title = "Validity of mouse mammary tumour models for human breast cancer: Comparative pathology",
abstract = "In March 1999, a panel of distinguished pathologists was convened by the U.S. National Institutes of Health Breast Cancer Think Tank to develop a classification of breast lesions based on their examination of 39 models of Genetically Engineered Mice (GEM) associated mouse mammary cancer (Cardiff et al., 2000). The meeting, in Annapolis, Maryland, resulted in a published summary report from the Pathology Panel (Cardiff et al., 2000). The Annapolis consensus report, developed from the Panel's deliberations, pointed out that the mammary lesions of GEM were different from most (spontaneous) mouse mammary tumors and could be divided into three distinct categories: (1) lesions that resemble those found in spontaneous mouse mammary tumorigenesis, (2) lesions that have a unique {"}signature{"} tumor phenotype that was specific for the transgene, and (3) lesions that resemble those found in human breast diseases (Cardiff et al., 2000). This review emphasizes the proposed nomenclature and the differences between the models and human breast cancer with the intention of stimulating discussion and the development of new models.",
keywords = "Genetically engineered mice, Nomenclature, Transplantation, Validation",
author = "Robert Cardiff",
year = "2001",
month = "1",
day = "15",
doi = "10.1002/1097-0029(20010115)52:2<224::AID-JEMT1007>3.0.CO;2-A",
language = "English (US)",
volume = "52",
pages = "224--230",
journal = "Microscopy Research and Technique",
issn = "1059-910X",
publisher = "Wiley-Liss Inc.",
number = "2",

}

TY - JOUR

T1 - Validity of mouse mammary tumour models for human breast cancer

T2 - Comparative pathology

AU - Cardiff, Robert

PY - 2001/1/15

Y1 - 2001/1/15

N2 - In March 1999, a panel of distinguished pathologists was convened by the U.S. National Institutes of Health Breast Cancer Think Tank to develop a classification of breast lesions based on their examination of 39 models of Genetically Engineered Mice (GEM) associated mouse mammary cancer (Cardiff et al., 2000). The meeting, in Annapolis, Maryland, resulted in a published summary report from the Pathology Panel (Cardiff et al., 2000). The Annapolis consensus report, developed from the Panel's deliberations, pointed out that the mammary lesions of GEM were different from most (spontaneous) mouse mammary tumors and could be divided into three distinct categories: (1) lesions that resemble those found in spontaneous mouse mammary tumorigenesis, (2) lesions that have a unique "signature" tumor phenotype that was specific for the transgene, and (3) lesions that resemble those found in human breast diseases (Cardiff et al., 2000). This review emphasizes the proposed nomenclature and the differences between the models and human breast cancer with the intention of stimulating discussion and the development of new models.

AB - In March 1999, a panel of distinguished pathologists was convened by the U.S. National Institutes of Health Breast Cancer Think Tank to develop a classification of breast lesions based on their examination of 39 models of Genetically Engineered Mice (GEM) associated mouse mammary cancer (Cardiff et al., 2000). The meeting, in Annapolis, Maryland, resulted in a published summary report from the Pathology Panel (Cardiff et al., 2000). The Annapolis consensus report, developed from the Panel's deliberations, pointed out that the mammary lesions of GEM were different from most (spontaneous) mouse mammary tumors and could be divided into three distinct categories: (1) lesions that resemble those found in spontaneous mouse mammary tumorigenesis, (2) lesions that have a unique "signature" tumor phenotype that was specific for the transgene, and (3) lesions that resemble those found in human breast diseases (Cardiff et al., 2000). This review emphasizes the proposed nomenclature and the differences between the models and human breast cancer with the intention of stimulating discussion and the development of new models.

KW - Genetically engineered mice

KW - Nomenclature

KW - Transplantation

KW - Validation

UR - http://www.scopus.com/inward/record.url?scp=0035862955&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035862955&partnerID=8YFLogxK

U2 - 10.1002/1097-0029(20010115)52:2<224::AID-JEMT1007>3.0.CO;2-A

DO - 10.1002/1097-0029(20010115)52:2<224::AID-JEMT1007>3.0.CO;2-A

M3 - Review article

C2 - 11169869

AN - SCOPUS:0035862955

VL - 52

SP - 224

EP - 230

JO - Microscopy Research and Technique

JF - Microscopy Research and Technique

SN - 1059-910X

IS - 2

ER -